findmyKOL
Clinical trialNCT00466843UnknownPhase 2Interventional

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

SponsorOffice of Rare Diseases (ORD)Enrollment54Myelodysplastic Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Myelodysplastic syndrome (MDS) is a rare, potentially serious bone marrow disease. Currently available treatments for MDS have been only somewhat beneficial. The purpose of this study is to determine the effects of the medication antithymocyte globulin (ATG) in adults with MDS and to determine which individuals with MDS are most likely to benefit from treatment with ATG.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucla Oncology Center

    Los Angeles, California, United States

    Ronald Paquette, MD
    Not, yet, recruiting
  • H. Lee Moffitt Cancer Center

    Tampa, Florida, United States

    Alan List, MD
    Recruiting
  • Cleveland Clinic Foundation - Case Western University

    Cleveland, Ohio, United States

    Jaroslaw P. Maciejewski, MD, PhD
    Recruiting
  • Penn State University

    Hershey, Pennsylvania, United States

    Thomas P. Loughran, Jr., MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Antithymocyte GlobulinPrednisone
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2007
Primary completion
28 Feb 2010
Completion
28 Feb 2010
Last update posted
2 Jun 2009
Registered enrollment
54
Registry id
NCT00466843
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.